Search Results - "Dams, Geert"

Targeting ferroptosis protects against experimental (multi)organ dysfunction and death by Van Coillie, Samya, Van San, Emily, Goetschalckx, Ines, Wiernicki, Bartosz, Mukhopadhyay, Banibrata, Tonnus, Wulf, Choi, Sze Men, Roelandt, Ria, Dumitrascu, Catalina, Lamberts, Ludwig, Dams, Geert, Weyts, Wannes, Huysentruyt, Jelle, Hassannia, Behrouz, Ingold, Irina, Lele, Suhas, Meyer, Evelyne, Berg, Maya, Seurinck, Ruth, Saeys, Yvan, Vermeulen, An, van Nuijs, Alexander L. N., Conrad, Marcus, Linkermann, Andreas, Rajapurkar, Mohan, Vandenabeele, Peter, Hoste, Eric, Augustyns, Koen, Vanden Berghe, Tom

“…The most common cause of death in the intensive care unit (ICU) is the development of multiorgan dysfunction syndrome (MODS). Besides life-supporting…”
Get full text

Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect by Corremans, Raphaëlle, Vervaet, Benjamin A, Dams, Geert, D'Haese, Patrick C, Verhulst, Anja

“…Diabetic Kidney Disease (DKD) is a major microvascular complication for diabetic patients and is the most common cause of chronic kidney disease (CKD) and…”
Get full text

Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover by Huybrechts, Yentl, Evenepoel, Pieter, Haarhaus, Mathias, Cavalier, Etienne, Dams, Geert, Van Hul, Wim, D'Haese, Patrick C, Verhulst, Anja

“…Renal osteodystrophy (ROD) is a complex and serious complication of chronic kidney disease (CKD), a major global health problem caused by loss of renal…”
Get full text

Disturbances in Bone Largely Predict Aortic Calcification in an Alternative Rat Model Developed to Study Both Vascular and Bone Pathology in Chronic Kidney Disease by Neven, Ellen, Bashir‐Dar, Rida, Dams, Geert, Behets, Geert J, Verhulst, Anja, Elseviers, Monique, D'Haese, Patrick C

“…ABSTRACT Because current rat models used to study chronic kidney disease (CKD)‐related vascular calcification show consistent but excessive vascular…”
Get full text

A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats by Neven, Ellen, De Schutter, Tineke M, Dams, Geert, Gundlach, Kristina, Steppan, Sonja, Büchel, Janine, Passlick-Deetjen, Jutta, D'Haese, Patrick C, Behets, Geert J

“…The alternative phosphate binder calcium acetate/magnesium carbonate (CaMg) effectively reduces hyperphosphatemia, the most important inducer of vascular…”
Get full text

Differences in gastrointestinal calcium absorption after the ingestion of calcium-free phosphate binders by Behets, Geert J, Dams, Geert, Damment, Stephen J, Martin, Patrick, De Broe, Marc E, D'Haese, Patrick C

“…Both calcium-containing and noncalcium-containing phosphate binders can increase gastrointestinal calcium absorption. Previously, we observed that lanthanum…”
Get more information

Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients by Bervoets, An R.J, Spasovski, Goce B, Behets, Geert J, Dams, Geert, Polenakovic, Momir H, Zafirovska, Katica, Van Hoof, Viviane O, De Broe, Marc E, D'Haese, Patrick C

“…Various biochemical markers have been evaluated in dialysis patients for the diagnosis of renal osteodystrophy (ROD). However, their value in predialysis…”
Get full text

Role of dietary phosphorus and degree of uremia in the development of renal bone disease in rats by Oste, Line, Behets, Geert J, Dams, Geert, Bervoets, An R, Marynissen, Rita L, Geryl, Hilde, Van Hoof, Viviane O, De Broe, Marc E, D'Haese, Patrick C

“…The remnant kidney rat model has been extensively used for the evaluation of bone changes due to uremia. The present study aimed to assess the effect of the…”
Get more information

Can Intestinal Phosphate Binding or Inhibition of Hydroxyapatite Growth in the Vascular Wall Halt the Progression of Established Aortic Calcification in Chronic Kidney Disease? by Neven, Ellen, Opdebeeck, Britt, De Maré, Annelies, Bashir-Dar, Rida, Dams, Geert, Marynissen, Rita, Behets, Geert J., Verhulst, Anja, Riser, Bruce L., D’Haese, Patrick C.

“…Vascular calcification significantly contributes to mortality in chronic kidney disease (CKD) patients. Sevelamer and pyrophosphate (PPi) have proven to be…”
Get full text

Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats by Neven, Ellen, Dams, Geert, Postnov, Andrei, Chen, Bing, De Clerck, Nora, De Broe, Marc E., D’Haese, Patrick C., Persy, Veerle

“…Background. Hyperphosphataemia is a risk factor for arterial calcification contributing to the high cardiovascular mortality in patients with chronic kidney…”
Get full text

High-Resolution X-Ray Microtomography Is a Sensitive Method to Detect Vascular Calcification in Living Rats With Chronic Renal Failure by Persy, Veerle, Postnov, Andrei, Neven, Ellen, Dams, Geert, De Broe, Marc, DʼHaese, Patrick, De Clerck, Nora

“…OBJECTIVE—Chronic renal failure (CRF) is associated with a 10- to 20-fold increase in cardiovascular risk. Vascular calcification is a prominent feature of…”
Get full text

Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure? by BEHETS, Geert J, DAMS, Geert, VERCAUTEREN, Sven R, DAMMENT, Stephen J, BOUILLON, Roger, DE BROE, Marc E, D'HAESE, Patrick C

“…Adequate control of phosphate levels remains an important issue in patients with chronic renal failure (CRF). Lanthanum carbonate has been proposed as a new…”
Get full text

Spectrum of renal bone disease in end‐stage renal failure patients not yet on dialysis by Spasovski, Goce B., Bervoets, An R. J., Behets, Geert J. S., Ivanovski, Ninoslav, Sikole, Aleksander, Dams, Geert, Couttenye, Marie‐M., De Broe, Marc E., D'Haese, Patrick C.

“…Background. During the last few years the spectrum of renal osteodystrophy (ROD) in dialysis patients has been studied thoroughly and the prevalence of the…”
Get full text

Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats by Oste, Line, Bervoets, An R., Behets, Geert J., Dams, Geert, Marijnissen, Rita L., Geryl, Hilde, Lamberts, Ludwig V., Verberckmoes, Steven C., Van Hoof, Viviane O., De Broe, Marc E., D'Haese, Patrick C.

“…Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats. Patients with impaired renal function can accumulate…”
Get full text

Dose-dependent effects of strontium on bone of chronic renal failure rats by Schrooten, Iris, Behets, Geert J.S., Cabrera, Walter E., Vercauteren, Sven R., Lamberts, Ludwig V., Verberckmoes, Steven C., Bervoets, An J., Dams, Geert, Goodman, William G., De Broe, Marc E., D'Haese, Patrick C.

“…Dose-dependent effects of strontium on bone of chronic renal failure rats. We previously reported on increased bone strontium (Sr) levels in dialysis patients…”
Get full text

Development and reversibility of impaired mineralization associated with lanthanum carbonate treatment in chronic renal failure rats by Bervoets, An R.J., Oste, Line, Behets, Geert J., Dams, Geert, Blust, Ronny, Marynissen, Rita, Geryl, Hilde, De Broe, Marc E., D'Haese, Patrick C.

“…We have previously shown that administration of the new phosphate binder lanthanum (La) carbonate at high doses during 12 weeks induces a mineralization defect…”
Get full text

Effects of efficient phosphate binding on bone in chronic renal failure rats by Behets, Geert J, Gritters, Mareille, Dams, Geert, De Broe, Marc E, D'Haese, Patrick C

“…We recently reported that administration of high doses of lanthanum carbonate (1000 mg/kg/day) to chronic renal failure (CRF) rats can result in a…”
Get more information

Strontium incorporates at sites critical for bone mineralization in rats with renal failure by Oste, Line, Verberckmoes, Steven C., Behets, Geert J., Dams, Geert, Bervoets, An R., Van Hoof, Viviane O., Bohic, Sylvain, Drakopoulos, Michael, De Broe, Marc E., D'Haese, Patrick C.

“…We previously demonstrated the development of a mineralization defect during strontium administration and its reversibility after withdrawal in rats with…”
Get full text